Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
39 studies found for:    " November 17, 2010":" December 17, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed
Has Results
Vitamin D in HIV-Infected Patients on HAART
Conditions: Vitamin D Deficiency;   HIV
Intervention: Dietary Supplement: Vitamin D
22 Completed Preparing for International Prevention Trials Involving HIV-Infected Individuals in Care Settings
Condition: HIV
Intervention:
23 Unknown  HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings
Condition: HIV
Intervention: Behavioral: HIV prevention intervention
24 Completed
Has Results
A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)
Condition: Infection, Human Immunodeficiency Virus I
Interventions: Drug: Dolutegravir;   Drug: Atripla;   Drug: Abacavir/Lamivudine;   Drug: Abacavir/Lamivudine Placebo;   Drug: Dolutegravir placebo;   Drug: Atripla placebo
25 Completed Pilot Study of Metabolic Syndromes and HIV Infections in Indian Tibetans
Conditions: Metabolic Syndromes;   HIV Infection
Intervention:
26 Completed
Has Results
Will Having Alcohol Treatment Improve Functioning?
Conditions: HIV;   Alcoholism
Interventions: Drug: Naltrexone, 50mg, once per day for 4 months;   Other: Sugar pill, 50mg, once per day for 4 months
27 Completed Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients.
Condition: HIV Integrase, HIV Protease.
Interventions: Drug: Raltegravir;   Drug: Darunavir
28 Completed Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART.
Conditions: HIV;   Cardiovascular Disease
Interventions: Drug: raltegravir plus truvada;   Drug: Darunavir, ritonavir, tenofovir/emtricitabine (Truvada)
29 Withdrawn The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters
Conditions: HIV;   Pregnancy
Intervention: Other: Pharmacokinetics
30 Completed Cameroon Mobile Phone SMS Trial
Conditions: Adherence;   HIV
Interventions: Other: Mobile phone text message;   Other: Usual care
31 Terminated
Has Results
A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022
Condition: HIV-1
Interventions: Drug: lersivirine;   Drug: efavirenz;   Drug: etravirine
32 Completed Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
Conditions: HIV;   AIDS;   Opioid Dependence;   Drug Dependence
Intervention: Drug: Extended-Release Naltrexone
33 Recruiting Ondansetron, Alcohol Use, and Alcohol-Related Symptoms In HIV+ Persons
Conditions: Alcohol Abuse;   Alcohol Dependence
Interventions: Drug: ondansetron;   Drug: placebo ondansetron;   Drug: Ondansetron
34 Completed Adherence, Improvement Measure (AIM) System
Conditions: Patient Compliance;   AIDS
Interventions: Behavioral: SMS medication adherence;   Behavioral: No SMS adherence reminder
35 Completed Safety and Immunogenicity Study of a Candidate Tuberculosis Vaccine in Human Immunodeficiency Virus (HIV)-Positive Adults
Condition: Tuberculosis
Interventions: Biological: GSK's investigational vaccine 692342;   Biological: Physiological saline
36 Unknown  Effects of an Evidence Service on Community-based AIDS Service Organizations' Use of Research Evidence
Condition: Use of Research Evidence
Intervention: Other: SHARE (Synthesized HIV/AIDS Research Evidence)
37 Active, not recruiting Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection
Conditions: HIV Infection;   Recurrent Anal Cancer;   Recurrent Breast Cancer;   Recurrent Esophageal Cancer;   Recurrent Gastric Cancer;   Recurrent Metastatic Squamous Neck Cancer With Occult Primary;   Recurrent Non-small Cell Lung Cancer;   Recurrent Ovarian Epithelial Cancer;   Recurrent Salivary Gland Cancer;   Recurrent Squamous Cell Carcinoma of the Hypopharynx;   Recurrent Squamous Cell Carcinoma of the Larynx;   Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity;   Recurrent Squamous Cell Carcinoma of the Nasopharynx;   Recurrent Squamous Cell Carcinoma of the Oropharynx;   Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Recurrent Verrucous Carcinoma of the Larynx;   Recurrent Verrucous Carcinoma of the Oral Cavity;   Salivary Gland Squamous Cell Carcinoma;   Stage IV Anal Cancer;   Stage IV Breast Cancer;   Stage IV Esophageal Cancer;   Stage IV Gastric Cancer;   Stage IV Non-small Cell Lung Cancer;   Stage IV Ovarian Epithelial Cancer;   Stage IV Salivary Gland Cancer;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IV Squamous Cell Carcinoma of the Larynx;   Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Nasopharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity;   Stage IV Verrucous Carcinoma of the Larynx;   Stage IV Verrucous Carcinoma of the Oral Cavity;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: vorinostat;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Drug: carboplatin;   Drug: paclitaxel
38 Completed Understanding Medication Adherence Among HIV Patients
Condition: Patient Commitment Preferences for Medication Adherence
Intervention: Other: Survey to Understand Medication Adherence among HIV Patients
39 Completed Familias Unidas: Preventing Drug Abuse and HIV in Hispanic First Offenders
Conditions: Substance Use;   Unsafe Sexual Behavior
Intervention: Behavioral: Familias Unidas

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Study has passed its completion date and status has not been verified in more than two years.